# Dexamethasone Solution and Dexamethasone in Mucolox™

> **NCT04540133** · PHASE2 · COMPLETED · sponsor: **University of California, San Francisco** · enrollment: 29 (actual)

## Conditions studied

- Oral Lichen Planus
- Mucous Membrane Pemphigoid
- Pemphigus Vulgaris
- Chronic Graft-versus-host-disease

## Interventions

- **DRUG:** dexamethasone 0.5mg/5ml solution
- **DRUG:** dexamethasone 0.5mg/5ml solution in Mucolox™

## Key facts

- **NCT ID:** NCT04540133
- **Lead sponsor:** University of California, San Francisco
- **Sponsor class:** OTHER
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2020-12-26
- **Primary completion:** 2023-01-06
- **Final completion:** 2023-01-06
- **Target enrollment:** 29 (ACTUAL)
- **Last updated:** 2023-12-15


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT04540133

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT04540133, "Dexamethasone Solution and Dexamethasone in Mucolox™". Retrieved via AI Analytics 2026-06-04 from https://api.ai-analytics.org/clinical/NCT04540133. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*